Related Experiment Video
Updated: Oct 19, 2025
08:38
Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
1.4K
Neonatal Transplant in Hypoxic Injury
1Neuroscience and Aging Lab, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|September 24, 2021
Summary
Stem cell therapy using neurogenic astrocytes shows promise for treating neonatal hypoxic-ischemic encephalopathy (HIE). These cells can be cultured and transplanted to potentially repair brain injury, offering hope for long-term recovery.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Neonatal Care
Background:
- Neonatal hypoxic-ischemic encephalopathy (HIE) frequently results in lifelong disabilities despite therapeutic hypothermia.
- Stem cell therapy presents a potential therapeutic strategy for HIE during both acute and chronic phases post-injury.
Purpose of the Study:
- To explore the potential of neurogenic astrocytes as a cell replacement therapy for HIE.
- To outline methods for generating and culturing these astrocytes and testing their efficacy in HIE models.
Main Methods:
- Generation and culturing of neurogenic astrocytes as adherent monolayers.
- Induction of neuronal differentiation from astrocytes in vitro and in vivo.
- Establishment of a neonatal HIE model.
- Transplantation of cultured astrocytes into HIE animal models.
Main Results:
- Neurogenic astrocytes exhibit neural stem cell characteristics.
- These astrocytes can generate neuronal progeny.
- The study outlines protocols for cell cultivation and transplantation.
Conclusions:
- Neurogenic astrocytes are promising candidates for cell replacement therapy in HIE.
- Further research requires optimized protocols and rigorous testing of cell engraftment, survival, and integration in HIE models.
